Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

U.S. Amplifies Danger as Pretext to Aid Israel, Iran Says

Iran’s Foreign Ministry said the U.S. is amplifying threats in the Middle East to justify its backing of Israel and continue selling weapons.

The comments by Foreign Ministry spokesman Ramin Mehmanparast to reporters came after U.S. Defense Secretary Chuck Hagel described plans to sell Israel advanced weaponry, as a “very clear signal to Iran” about the possibility of an Israeli military strike against its nuclear facilities.

“Israel and the U.S. see the threat of Iran in exactly the same” way, Hagel said on April 21, on his way to Israel.

“U.S. arms contracts and ready help to the Zionist regime isn’t a new matter,” Mehmanparast said in Tehran today. Hagel’s comments “are justification to overplay the danger, which the U.S. has fueled in the region, and the ultimate goal is to sell weapons.”

The U.S. questions Iran’s assertion that its nuclear program is designed to stimulate electricity generation and medical research. Israel has said Iran must be pressured to curb its nuclear program with a “credible military threat.” The U.S. and Israel have both said a military solution may be needed.

“Our country is powerful enough to defend its rights and its sovereignty,” Mehmanparast said. “These governments should stop psychological moves launched against our nation, which will only make our people more resilient.”

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.